Keith A. Canada
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Microbial bioremediation and biosurfactants, Psoriasis: Treatment and Pathogenesis, Chemical Synthesis and Analysis
Most-Cited Works
- → Design of an in vitro biocatalytic cascade for the manufacture of islatravir(2019)616 cited
- → A specific antidote for dabigatran: functional and structural characterization(2013)561 cited
- → Directed Evolution of Toluene ortho -Monooxygenase for Enhanced 1-Naphthol Synthesis and Chlorinated Ethene Degradation(2002)177 cited
- → Aerobic degradation of tetrachloroethylene by toluene-o-xylene monooxygenase of Pseudomonas stutzeri OX1(2000)152 cited
- → A kinase-cGAS cascade to synthesize a therapeutic STING activator(2022)129 cited
- → Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody(2015)122 cited
- → Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies(2017)85 cited
- → DABIGATRAN ANTICOAGULANT ACTIVITY IS NEUTRALIZED BY AN ANTIBODY SELECTIVE TO DABIGATRAN IN IN VITRO AND IN VIVO MODELS(2011)79 cited
- → Rhizosphere Competitiveness of Trichloroethylene-Degrading, Poplar-Colonizing Recombinant Bacteria(2000)63 cited
- → A chemoenzymatic strategy for site-selective functionalization of native peptides and proteins(2022)53 cited